These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7018819)

  • 1. [Treatment with 5-fluorouracil: randomized study comparing an oral preparation with intravenous administration].
    Veronesi A; Talamini R; Mauro Trovò G; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Clin Ter; 1981 May; 97(4):389-93. PubMed ID: 7018819
    [No Abstract]   [Full Text] [Related]  

  • 2. From 5 fluorouracil to the new oral fluoropyrimidines: a brief overview of four decades of clinical investigations.
    Sulkes A
    Isr Med Assoc J; 2001 Apr; 3(4):278-81. PubMed ID: 11344842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of 5-fluorouracil--with special reference to the evaluation of the intravenous administration method].
    Hamaguchi E; Utsunomiya J; Hishigi S; Nakamura T
    Gan No Rinsho; 1968 Sep; 14(9):793-803. PubMed ID: 5750379
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of solid tumors with N-1-(2'-tetrahydrofuryl)-5-fluorouracil (FT-207) alone and in combination: comparison of intravenous and oral administration].
    Saito T; Wakui A; Yokoyama M; Takahashi H; Takahashi K
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):395-406. PubMed ID: 4476739
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factorial designs for randomized clinical trials.
    Byar DP; Piantadosi S
    Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of 5-fluorouracil in surgical field].
    Suzuki T; Nishimura G; Imamura K; Sugahara K; Fujii Y
    Gan No Rinsho; 1969 May; 15(5):459-68. PubMed ID: 5387578
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids and fluorouracil toxicity.
    Horton J; Olson KB; Hosley HF
    Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determinaton of concentration of 5-fluorouracil after intravenous and intra-arterial route of administration of he preparation].
    Agadzhanova NN; Gol'dman BG; Smolianskaia AZ
    Lab Delo; 1968; 2():114-5. PubMed ID: 4185790
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus orally UFT in plasma of same patients].
    Hirata K; Sasaki K; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1409-11. PubMed ID: 8346941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Natural cholecystokinin compared with synthetic cholecystokinin in oral cholecystography. A prospective randomized study].
    Rasmussen PC; Pedersen PR; Hansen KF
    Ugeskr Laeger; 1985 Mar; 147(13):1117-9. PubMed ID: 3887709
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    N Engl J Med; 1973 Apr; 288(17):910-2. PubMed ID: 4571248
    [No Abstract]   [Full Text] [Related]  

  • 15. A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005).
    O'Donnell A; Punt CJ; Judson I; Van Maanen L; Suttle AB; Ertel P; Beale P
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):58-66. PubMed ID: 12497207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy--present status and problems].
    Furue H
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):589-96. PubMed ID: 10234287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study.
    Papadeas E; Naxakis S; Riga M; Kalofonos Ch
    Eur J Oncol Nurs; 2007 Feb; 11(1):60-5. PubMed ID: 16829196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
    Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
    J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience.
    Lima AP; del Giglio A
    Eur J Cancer Care (Engl); 2005 May; 14(2):151-4. PubMed ID: 15842464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.